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Genetic controlofcellular and humoral immune responses to pathogenic viruses
has been studied using several different types ofviruses and afewhost species (reviewed
in references 1-5) . Most ofthese studies, however, focusedon therecognition ofviral
antigens on infected target cells by cytotoxic T cells, and little is known about how
the induction of immune responses to pathogenic viruses is genetically controlled
(4, 5) . Of course, immune response (Ir) t gene phenomenahave been described and
their mechanisms have been intensively analysed using synthetic and natural an-
tigens of limited numbers of antigenic determinants (reviewed in references 6 and
7) . Consequently, it hasbeen considered likely that Ir genephenomena control host
immune responses to viral antigens through the mechanisms quite similar to what
have been observed with synthetic peptides (5, 8) . In fact, thepresence of viral antigen-
specific, H-21 region-restricted helperT cells has been demonstrated in mouse models
of influenza virus (4, 9), Sendai virus (5), reovirus (10), and herpes simplex virus
(11, 12) infections . However, direct demonstration ofIr gene-controlledresponder/non-
responder phenotypes to viral antigens has been rarely presented (13), except in the
humoral immune responses of inbred mice to human hepatitis B virus surface an-
tigen (14, 15). In the present studywe have investigated cellular mechanisms forthe
influence ofH-2 on theinduction ofprotective immunity against murine retrovirus
infection and identified H-2-linked Ir genes controlling the T cell responsiveness
to the viral envelope glycoprotein .
Friend murine leukemia virus complex (FV) is a retrovirus complex composed
ofreplication competent Friend murine leukemia helper virus(FMuLV) and defec-
tive Friend spleen focus-forming virus(SFFV) (16) . FV causes extremely rapid progres-
sion of an erythroleukemia associated with severe immunosuppression when injected
to immunocompetent adult mice or newborn mice of susceptible strains (17, 18).
This FVinduced leukemia usually results in massive splenomegaly occurring 1-2
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wk after virus inoculation and in death of infected animals within 1-3 mo. However,
in certain mouse strains, spontaneous recovery from leukemic splenomegaly occurs
2-4 wk after virus inoculation and recovered mice show long-lasting resistance to
FV (17, 19) . The production of antiviral antibodies is required for the recovery and
is associated with the clearance of viremia (20, 21) . In addition, we have detected
both cytotoxic effector cells and proliferative L3T4+ cells specific for FVinduced
leukemia cells in FVinfected mice (22-24) . In FVinfected mice, a gene(s) in H-2K
or I region influences the ability to generate leukemia cell-specific proliferative T
cells, whereas the H-2D locus appears to control the time course of development
of this T cell response (24) . More recently we studied protective immunization of
mice against FV with a recombinant vaccinia virus that expressed the env gene of
FMuLV (25, 26) . By using several H-2 recombinant mouse strains, a gene or genes
in H-2K or I region was shown to control the development of protective immunity
after immunization with the vaccinia-F-MuLV env (26) . Moreover, this protective
immunity was functionally mediated by priming of helper T cells (25, 26) .
These results strongly suggest that a gene(s) in H-2K or I region controls T cell
responsiveness to the FMuLV env gene products . In this paper we provide direct
evidence that H-2I region (class II loci) gene products expressed on APCs function
as the restriction elements for the T cell recognition of FMuLV envelope protein .
Materials and Methods
Animals .
￿
C57BL/IOSnj, B10.A/SgSnj, A.BY/Snj , A/WySnj, B10.MBR/SxEg, andB6.C-
H-2°°''2/KhEg mice were purchased from The Jackson Laboratory, Bar Harbor, ME .
B10.A(1R)/Sg, B10.A(4R)/Sg, B10.A(5R)/Sg, and B10.A(18R)/Sg mice were kindly provided
by Dr. Jack Stimpfling (McLaughlin Research Institute, Great Falls, MT) from his colony.
To eliminate possible effects of the Rfv-3 gene (21, 27) on T cell and/orAPC functions, all
mice used in this study were F, hybrids with the Rfv-3*ir genotype . F, hybrid mice were bred
at the Rocky Mountain Laboratories (RML), Hamilton, MT. H-2 alleles and parameters
of anti-FV immune responses of the H-2 congenic and recombinant mice used in this study
are summarized in Table I . Both male and female mice 2-6 mo old were used ; however, all
sources ofAPC and T cells were age and sex matched in each experiment .
Purified Viruses .
￿
Sucrose density purified virions of Rauscher murine leukemia virus
(RMuLV) from JLS-V9 leukemia cell line (No. 1089 and 1090) were kindly provided by the
Biological Carcinogenesis Program, National Cancer Institute, Frederick Cancer Research
Facility, Frederick, MD. Virions of an infectious molecular clone of FMuLV, FB-29 (29),
were purified from culture supernatant of chronically infected, Fischer rat embryo (FRE)
cells orMus dunni cells by using a previously described Percoll density gradient method (30) .
Purity ofthe virions was confirmed by SDS-PAGE. FV and Rauscher virus complex are bio-
logically quite similar (16) and FMuLV andRMuLV are immunologically highly crossreac-
tive sharing a large number of antigenic determinants (31, 32) . Therefore, we used both of
these virus strains to test FMuLV-specific T cell responses . Purified virions were dialyzed
against Dulbeccds PBS without the divalent cations (D-PBS- ), and were inactivated by UV
irradiation (33) . Inactivation of plaque-forming activity was determined by a focal im-
munofluorescence assay (34) on live Mus dunni cells .
Preparation ofTNP-KLH.
￿
TNP haptens were conjugated to KLH (Calbiochem-Behring
Corp., La Jolla, CA) by a standard method (35) . The preparation used in this study was
conjugated with 7 .7 mol TNP/105 g KLH .
Immunization ofMice.
￿
Mice were immunized in the hind foot pads with 100 pg of the virions
or TNP-KLH emulsified in CFA (Difco Laboratories, Inc., Detroit, MI) . The recombinant
vaccinia virus expressing the entire env gene from the FMuLV clone 57 (25) and the control
recombinant vaccinia virus expressing the influenza hemagglutinin (HA) gene (36) were kindly
provided by Dr. Bernard Moss, Laboratory of Viral Diseases, National Institute ofAllergy5
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TABLE I
Alleles at H-2 Loci and Parameters ofAnti-FV Immune Response
of the Mouse Strains Used in This Study
Protective
Based on references 8 and 28 . In each strain of mice underlined loci are sharing the same allele with the
H-2b haplotype . Previously used term of I region corresponds to Ap-Ea loci .
Heterozygous H-2"'b (B10.A x A.BY)F1 mice did not recover from splenomegaly if 1,500 SFFU of FV
were inoculated . However, if given 150 or 15 SFFU of FV, a significant number of the same strain of
mice recovered (17, 19) .
Mice were immunized with the vaccinia-F-MuLV env recombinant vaccine . 30 d later, they were challenged
with i .v . inoculation of 1,500 SFFU ofFV (25, 26) .
Ea gene of the H-2b haplotype is defective . Therefore, (C57BL/10 x A.BY)F1 mice do not express any
EaEp complex . However, (BlO.A x A.BY)FI, (B10.A(5R) x A/WySn)Fi, (B10.A(18R) x A/WySn)Fl,
(B10.MBR x A.BY)F1, and (B6.C- H-21',12 x A/WySn)Fl express two types of I-E molecules : EakEpk
and EakEpb . All other mouse strains in this table express only one type of I-E molecule: EakEgk . See refer-
ence 28 for detailed explanation .
and Infectious Diseases, Bethesda, MD. Mice were immunized by exposing a needle scratch
at the base of the tail to 101 plaque forming units (PFU) of recombinant vaccinia virus in 1 Al .
Preparation ofAPCs. Peritoneal exudate cells (PEC) were elicited by intraperitoneal injec-
tion of 0.5-1.0 ml 2 .5% oyster glycogen (Type II ; Sigma Chemical Co., St. Louis, MO) in
D-PBS - (37) . PEC were harvested 3-4 d after the injection and were irradiated (2,000 rad)
in a 137CS y-irradiator . Irradiated PEC were washed once, suspended at 10 7 cells/ml in
prewarmed phosphate buffered balanced salt solution (PBBS) containing 10% FCS of a lot
selected for low background stimulation ofDNA synthesis (HyClone Laboratories, Inc ., Logan,
UT) and were pulsed with an antigen at 37'C for i h . Antigen-pulsed PEC were washed
once with cold D-PBS- and three times with cold PBBS. Control unpulsed PEC were pre-
pared by exactly the same procedure except that D-PBS- was added to prewarmed PBBS
instead of an antigen.
TheAPC activity ofglycogen-elicited PEC was confirmed by comparison with that ofspleen
adherent cells analyzing stimulator cell dose-response curves, and the glycogen-elicited PEC
were usually better as APC than spleen adherent cells were. Therefore, we used these PEC
as APC in all the following experiments .
Antigen dose-response curves ofT cell proliferative response were analyzed in preliminary
experiments forTNP-KLH and purified virions. In both cases, resultant dose-response curves
were rather flat throughout the concentration range from 10 to 100 Pg/ml, and the highest
magnitude of proliferation was observed when PEC were pulsed with 100 wg/ml of antigen .
Therefore, this concentration was used to pulse PEC throughout further experiments .
T Lymphocyte Proliferative Assay.
￿
Nylon wool-passed T cells were prepared by a standard
technique (35, 38) from the pooled spleens and lymph nodes of two to three mice from im-
munized and unimmunized control groups . The average composition ofthe nylon wool-passed
Strain
H-2
haplotype K
Alleles at
AD Aa
H-2 loci'
Ep Ea S D
Recovery from
splenomegalyt
High Low
dose dose
immunity
after
vaccinia-
F-MuLV env4
(C57BL/10 x A.BY)F1 blb blb blb blb blb -/- 11 blb blb + + +
(B10.A x A.BY)F1 alb klb klb klb klb kl- d1b dlb - + +
(B10.A x A/WySn)Fl ala k1k k1k k1k k1k k1k did d1d - - -
(BIO.A(IR) x A/WySn)Fl h1/a k1k k1k k1k k1k k/k did _b/d - ND -
(B10.A(4R) x A/WySn)Fl h4la k1k k1k k1k k1k -/k bld bld - ND -
(B10.A(5R) x A/WySn)Fl i5la blk blk blk blk k1k d1d d1d - ND +
(B10.A(18R) x A/WySn)Fl i18/a blk blk blk blk -1k bld d1d - ND +
(B10.MBR x A .BY)F1 bgllb b1b k1b k/b k/b k/- k1b q/b ND ND ND
(BlO.MBR x A/WySn)Fl bql/a blk k1k k1k k1k k1k k/d q/d ND ND ND
(B6.C- H-2b,12 x A/WySn)Fl bm121a b/k bm12/k blk b/k -1k b/d bld ND ND ND1590
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T cell preparation determined by immunofluorescence was >90% Thy-1.2' and <3% sur-
face Ig' . 2-5 x 10 5 T cells (exact numbers are described for each experiment in Results sec-
tion) were cultured with various numbers ofantigen-pulsed or unpulsed APC in 200 ul Click's
medium (39) supplemented with 50 wg/ml gentamicin sulfate and 7.5% heat-inactivated FCS
of the selected lot in a well of round-bottomed 96-well plastic tissue culture plates (Linbro
No. 76-042-05 ; Flow Laboratories, McLean, VA) . Cells were pulsed with 1 WCi/well
[ 3H]thymidine (6.7 Ci/mol ; New England Nuclear, Boston, MA) for a final -20 h, harvested
on glass fiber filters, and the incorporation of [3H]thymidine into DNA was measured with
a liquid scintillation counter . In several preliminary experiments kinetics oftheT cell prolifer-
ation under the stimulation of antigen-pulsed PEC was analyzed, and a peak in incorpora-
tion of the thymidine was always observed when it was added 3 d after the start ofthe culture .
Therefore, in all further experiments, thymidine incorporation was measured after 3 d of
culture . The average amount of [3H]thymidine incorporation was calculated for each number
ofAPC from the results of four parallel wells and the magnitude of antigen-specific T cell
proliferative response was expressed by Ocpm values using the following formula: Acpm =
(average incorporation of [3H]thymidine under the stimulation of antigen-pulsed APC) -
(average incorporation of [ 3H]thymidine under the stimulation of unpulsed APC) .
mAb to Class I and Class IIMHC Antigens and Blocking ofT Cell Proliferation.
￿
Mouse ascites
fluids containing the following mAbs were purchased from Organon Teknika Corporation,
Durham, NC : anti-I-Ab .d (Ia.m8) IgM from clone 28-16-8S (40), and anti-Kb .r (H-2 .m83)
IgM from clone 28-13-3S (40) . Low molecular weight, nonspecific inhibitory substances were
removed from the ascites by ultrafiltration (41) . Purified IgG of the following mAbs from
culture supernatant ofhybridoma cells were kindly provided by Dr . LindaL. Perry, Labora-
tory of Persistent Viral Diseases, RML : anti-I-Ak .e.r ,s (Ia.m27) IgG2a from clone 10-3.6 (42),
anti-I-Ab,d . p , q .v (Ia.m25) IgG2a from clone 25-9-17S (40), anti-I-Ek .d .P .r (Ia.m7) IgG2a from
clone 14-4-4S (43), and anti-Kk .P.q ,, (H-2.m93) IgG2a from clone 11-4 .1 (42) . To block
antigen-specificT cell proliferative responses, various dilutions ofthe mAbs or control Click's
medium were added to the culture and were present throughout the culture period (41) .
Results
Influence of the H-2 Haplotype ofAPC on Proliferative Response of T Cells Primed with
R-MuLV . Since homozygous H-2a a mice failed to develop protective immunity
against FV after immunization with the vaccinia-FMuLV env recombinant (26) and
T cells from FVinfected H-2 a mice did not show significant proliferative response
under the stimulation ofFVinduced erythroleukemia cells (24), it was postulated
that T cells in H-2° mice could not be primed with the F-MuLV antigens . To test
whether T cells could recognize the viral antigens in the context of H-2aMHC mol-
ecules, we first examined proliferative response of nylon wool-purified T cells from
immunized H-2" mice under the stimulation of H-2 a and H-2" PEC . Because
of the availability of a large quantity of purified virions, RMuLV, which is highly
crossreactive with FMuLV, was used to immunize mice along with CFA. As shown
in Fig. 1, H-d" PEC pulsed with UV-irradiated RMuLV induced three to four
times higher peak proliferative response ofRMuLV-primed H-2` T cells than
pulsed H-2 a PEC did . This difference in APC activity to RMuLV-primed H-2"
T cells between H-2° and H-2' PEC was not because of the difference in kinetics
ofT cell proliferation because both under the stimulation ofH-2° PEC and under
the stimulation of H-2" PEC the peak of thymidine incorporation was observed
when [3H]thymidine was added on day 3 (data not shown) . RMuLV-specific T cell
proliferative responses were analyzed repeatedly from 17 to 31 d after priming of
the H-21 mice and peak Ocpm values under the stimulation ofH-2' or H-2' PEC
were always three to seven times higher than those under the stimulation ofH-21°0
x
E a
a
t
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FIGURE 1 .
￿
Proliferative responses of the T cells from
H-2`b mice immunized with the purified whole virions
ofR-MuLV inCFA. Responder T cells were prepared
31 d afterimmunization and were cultured with indi-
cated numbers of PEC harvested from (C57BL/10 x
A.BY)FI (H-2b1b) or (BIO.A x A/WySn)F I (H-2°~°)
mice . Dashedline showsthemaximum level ofprolifer-
ative response exhibitedby Tcellsfrom unprimed con-
trol H-2°4 mice under the stimulation of antigen-pulsed
PEC (mean + SD). Each Acpm valueshowsmean t SD.
PECs (Table II) . Therefore, the observed difference in APC activity between H-21 '°
and H-2b4 PEC was not caused by a difference in the time course of primingbetween
H-2a-restricted and H-2b-restrictedT cell populations . Thus, these results clearly
showed that the PEC having the H-2b haplotype were more efficient than those
having only the H-2° haplotype to present the viral antigens toRMuLVprimed
H-2" T cells . In addition, there was no significant difference between the APC ac-
tivity of heterozygous H-2 b PECs and that ofhomozygous H-Z" PEC to RMuLV-
primed T cells, confirming the dominance of H-2b haplotype.
TABLE II
Proliferative Response of T Cellsfrom the (BI0.A x A.BY)F1 Mice
Immunized with R-MuLV in CFA under the Stimulation ofAPC
That Have Different H-2 Haplotypes
Stimulator cell dose-response curves were analyzed in all of these experiments and the data
are represented by peak proliferative response . No significant proliferative response ofTcells
from unimmunized control mice under the stimulation of R-MuLV-pulsed PEG was ob-
served in any of these experiments .
PEG were pulsed with UV-irradiated R-MuLV .
Acpm values in boxes are significantly higher than thoseunder the stimulation ofH-2d°PEC
in each experiment (p < 0.05 by Student's t test) .
Days No . of [3H]Thymidine incorporation by 2 x 105T cells
Exp.
after
priming
PEG
per well"
(Acpm)
H-2" b PEG
under the stimulation
H-2a" PEG
of
H -2a"° PEG
1 17 10 5 6,460 t 1-876 6,764 t 744 1,632 t 788
2 19 3 x 104 7,608 t 811 ND 2,508 f 1,084
3 24 3x 10 4 8,014 t 1,007 7,582 t 996 2,744 t 1,156
4 31 3 x 10 4 15,377 t 1,706 ND 2,248 t 2,6371592
￿
Ir GENE CONTROL OF ANTI-FRIEND MuLV T CELL RESPONSE
Proliferative Response ofTCells Primed with TNP-KLH.
￿
To eliminate the possibility
that the above-described difference in the R-MuLV-primed T cell proliferative re-
sponse under the stimulation of H-daa and H-266 PEC was a result of general func-
tional impairment of H-21° PEC, we tested the proliferative response of H-Z" T
cellsprimed with TNP-KLH as acontrol antigen. As shown representatively in Fig .
2, there was no general impairment in APC activity ofH-2° PEC, compared with
that ofH-2b b PEC, that could explain the three to sevenfold difference in R-MuLV-
specific T cell proliferative response .
Proliferative Response ofF-MuLVEnvelope-speck TCells under the Stimulation ofH-2a
and H-2"b PEC Purified R-MuLV virions used as immunogens in the previous
experiments contain envelope, core, andpolymerase proteins . However, earlier studies
(25, 26) indicated that theFMuLV envelope protein by itself could induce protec-
tive immunity againstFV Furthermore, H-2 haplotype had a significant influence
on induction ofthe protective immunity with the vaccinia-FMuLV envvaccine(26) .
Therefore, to analyze the influence of the H-2 onAPC control of theFMuLVenve-
lope-specific T cell response, we immunized mice with the recombinant vaccinia
virus that expressed the entire FMuLV env gene, but not the gag or pol genes . T
cells from the H-dab mice immunized with the vaccinia-FMuLV env proliferated
under the stimulation of H-2"b PEC pulsed with UVirradiated FMuLV (FB-29)
orRMuLV, andthere was no significant difference in the stimulator cell dose-response
curves (Fig . 3, A and B) or in theantigen dose-response curves (not shown) obtained
using these two virus strains, confirming the crossreactivity of the viruses at theT
cell level . Importantly, while H-2111 PEC induced significant proliferative responses
ofFMuLV envelope-specificT cells, only marginal proliferative responseswere ob-
served when theT cells were stimulated with H-2a PEC (Fig . 3) . TheT cells from
the H-dab mice immunized with the control vaccinia-influenza HA did not
FIGURE 2 .
￿
Proliferative responses ofTNP-KLH-primed,
H-dab T cells under the stimulation of antigen-pulsed,
H-2a'a or H-2611 PEC. Experiments were done repeatedly
from 17 to 40 d after immunization, and this representa-
tive figure shows the result on day 17 . Each Acpm value
shows mean t SD. Dashed line shows the maximum level
ofproliferative response exhibited by control unprimed T
cells under the stimulation ofTNP-KLH-pulsedPEC (mean
+ SD) .MIYAZAWA ET AL .
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FIGURE 3 . Proliferative re-
sponses of F-MuLV envelope-
specific H-214T cells under the
stimulation of antigen-pulsed,
H-21 ° or H-2616 PEC. Experi-
ments were done repeatedly
from 16 to 32 d after immuni-
zation and all the results were
similar to this representative
figure. 4 x 10 5T cells were cul-
tured in a well of 96-well culture
plates in this particular experi-
ment . PEC were pulsed either
withUVirradiated RMuLV (A)
or withUVirradiated F-MuLV
(FB-29) (B) . Each Acpm value
shows mean t SD. Dashed
lines show maximum levels of
proliferative response exhibited
by T cells from the H-2a~6 mice
immunized with the control
vaccinia-influenza-HA vaccine
under the stimulation of R-
MuLV orRMuLVpulsedPEC
(mean + SD) .
proliferate under thestimulation ofPEC pulsed with purified FMuLV orR-MuLV,
showingthelack of cross-stimulation ofvaccinia virus-specificT cells with thepurified
MuLVs . Thus, this result suggested that FMuLV envelope-specific T cells from
H-2" mice recognized the envelope protein in the context ofH-26MHC products
but the same T cells failed to recognize the antigen in the context of H-2a MHC
products .
Mapping ofthe Ir Genefor F-MuLVEnvelope Protein in Ap, Aa, or Ep Loci ofthe H-2.
To determine thegene locus(or loci)within the H-2 that influences theAPC activity
to FMuLVenvelope-specific T cells, we first tested several H-2 recombinant mouse
strains as the sources ofPEC. As shown in Fig. 4, the PEC from (B10.A(5R) x
A/WySn)Fi or (B10.A(18R) x A/WySn)Fl mice having the b allele at least at the
K, AO, Aa, and Ep loci of the H-2 stimulated the proliferative response of the
FMuLV envelope-specific H-2°lb T cells . However, the PECs from (B10.A(1R) x
A/WySn)Fi or (B10.A(4R) x A/WySn)Fi mice having only the k allele at these loci
did not evoke significant proliferative response even when they had the b allele at
the Ea, S, and/orD loci of the H-2 .
To distinguish the possible influence of the b allele at the K locus from that of
the b allele at the AD, A,, and /or Ep loci, we next used the B10.MBR strain of mice
that has a recombination between the K and Ap loci of the H-2 (see Table I) . When
PEC from (B10.MBR x A.BY)Fi and (B10.MBR x A/WySn)Fl mice were used
to stimulate H-2b T cells primed specifically for F-MuLV envelope protein,
significantlyhigher envelope-specific proliferative responseswere observed underthe
stimulation of(B10.MBR x A.BY)Fj
(Kb1b, IAk 1b) PEC (Table III) . Thus, thePEC
having the b allele both at theK and I-A loci were more efficient at presenting the
antigen to FMuLV envelope-specificT cells than were thePEC having the b allele
only at the K locus . However, the Acpm values obtained under the stimulation of1594
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(B10.MBR x A/WySn)Fj PEC fluctuated from marginal to significant levels, pos-
sibly because of incomplete depletion of APC from the responder T cell prepara-
tions in some experiments and augmentation of the envelope-specific proliferative
responses bymixedlymphocyte reaction caused by theincompatibilityat theD locus .
In fact, the background proliferative responses under the stimulation of unpulsed,
(B10.MBR x A.BY)F1 or (B10.MBR x A/WySn)Fl PEC were always twice as high
as those under the stimulation of syngeneic H-2°16 PEC . To eliminate the difficul-
ties caused by the D-locus incompatibility and possible contamination of APC to
TABLE III
Proliferative Response ofF-MuLV Envelope-specific, H-2°1b T Cells under the Stimulation of
(B10.MBR x A.BY)F or (B10.MBR x A/WySn)F1 PEC Pulsed with
UV-irradiated F-MuLV (FB-29)
FIGURE 4 .
￿
Proliferative responses of FMuLV envelope-
specific, H-2"'b T cells under the stimulation ofantigen-pulsed
PEC from four H-2 recombinant mouse strains . Experiments
were done repeatedly from 21 to 32 d after immunization and
all the results were similar to this representative figure . T cells
were prepared from (B10A x A.BY)F1 mice immunized with
the vaccinia-F-MuLV ena vaccine, and 2 x 10 5 T cells per well
were cultured withPEC pulsed withUVirradiatedRMuLV.
For H-2 alleles ofthe sources of PEC, see Table I . Each Acpm
value shows mean ± SD. Dashed line shows the maximum level
of proliferative response exhibited by control vaccinia-influenza-
HA-primed T cells under the stimulation of R-MuLVpulsed
PEC (mean + SD) .
' (B10.A x A.BY)FI (H-2~6) mice were immunized with the vaccinia-F-MuLV ena recombinant vaccine .
In some experiments mice were boosted 3 mo later by repeating the same immunization . The spleen and
lymph node cells from two immunized mice were pooled to prepare T cells in each experiment .
1 Stimulator cell dose-response curves were analyzed in each ofthese experiments and the results are repre-
sented here by peak Acpm values .
4 These Acpm values are significantly higher than the other value of the same experiment (p < 0.05 by Stu-
dent's t test) .
Days after
[ 3H]Thymidine incorporation by
Immunization of
(B10.A x A.BY)Fj
final
immuni-
No . of PEC
added per
5 x 105 T cells (Acpm value)
the stimulation of PEC from
under
mice in vivo * zation wellt (BIO.MBR x A.BY)Fj (B10.MBR x A/WySn)Fl
Once 16 10 5 4,958 ± 2,309 1,902 t 1,307
Once 17 3 x 10 4 23,050 t 2,2775 13,711 ± 1,373
Once 28 10 5 23,534 t 1,3755 7,106 t 473
Once 29 105 16,358 f 8774 4,909 t 952
Twice 10 105 40,773 t 2,190 2,084 t 1,229
Twice 13 3 x 10 4 24,146 ± 3,2074 14,799 t 1,713T cell preparations, syngeneic T cell proliferative responses were analyzed using
both immune T cells and PEC from (B10.MBR x A.BY)F1 and (B10.MBR x
A/WySn)Fl mice . As shown in Fig. 5, FMuLU envelope-specific T cells from im-
munized (B10.MBR x A.BY)Fi mice proliferated strongly under the stimulation
of antigen-pulsed, syngeneic PEC, while T cells from (B10.MBR x A/WySn)FI
mice immunized with the same vaccinia-FMuLU env vaccine were almost totally
nonresponsive to the stimulation with syngeneic PEC pulsed with FMuLU Thus,
T cells were not primed with FMuLU envelope protein in (B10.MBR x
A/WySn)Fl mice that are K` but I-A' . These results strongly indicated that
proliferative T cells recognized the FMuLU envelope protein in the context of I-
Ab, hybrid I-Ak/b, and/or hybrid I-E` molecules, but not in the context of Kb, Kk ,
I-A', or I-Ek molecules.
Blocking of T Cell Proliferation by Anti-IA' and Anti-I-E* mAbs. To demonstrate
directly theMHC molecules that function as the restriction elements in the recogni-
tion ofFMuLV envelope, we examined blocking ofT cell proliferative responses
with several anti-H-2 mAbs . Fig. 6 shows representative results of repeated anti-
body dose-response analyses . Under the stimulation of H-dblb PEC (Fig . 6A) both
of the two anti-I-Al mAbs strongly inhibited the FMuLU envelope-specific T cell
proliferative response, whereas the anti-I-Ek and anti-Kb mAbs did not . When
H-2" PEC were used to stimulate the envelope-specificT cells (Fig . 6 B), both the
anti-I-A' mAbs, again, significantly inhibited the proliferative response . However, more
importantly, the anti-I-AkmAb did not block the proliferative response at all (arrow),
and neither the anti-Kb nor the anti-Kk mAb inhibited the envelope-specificT cell
proliferation. Interestingly, anti-I-EkmAb 14-4-4S exhibited an intermediate inhibi-
tory effect on the envelope-specific T cell proliferative response (arrow) .
The lack of inhibition of the FMuLU envelope-specific T cell proliferative re-
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FIG. 5 .
￿
Proliferative responses ofFMuLUenvelope-spe-
cific T cells from (B10.MBR x A.BY)Fi and (B10.MBR x
A/WySn)Fl mice under the stimulation of syngeneicPEC.
Mice were immunized with the vaccinia-FMuLUenvrecom-
binant vaccine and immuneT cells were prepared from 16
to 29 d after the immunization . PECwere pulsedwith UV-ir-
radiatedFMuLU (FB-29), and indicated numbers were cul-
tured with 5 x 10 5T cells per well . The results of repeated
experiments were completely consistent with this represen-
tative figure. Each Acpm value shows mean t SD .n
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FIGURE 6 .
￿
Inhibition of FMuLV envelope-specific and
TNP-KLH-specificT cell proliferative responses with anti-
K, anti-I-A, and anti-I-E mAbs . Nylon wool- passedT cells
were prepared from (B10.A x A.BY)Fj mice immunized
either with the vaccinia-FMuLV env vaccine (A, B) orwith
TNP-KLH in CFA (C-E). PEC were harvested from
(C57BL/10 x A.BY)Fi (H-gem) mice (A, C, (B10.A x
A.BY)Fj (H-2de) mice (B, D), or from (B10.A x A/WySn)-
F7 (H-2°1°) mice (E), and were pulsed with UVirradiated
FMuLV(FB-29~ (A, B) or withTNP-KLH (C-E). 105 (A,
B, D) or 5 x 10 (C, E) PEC were cultured with 2 x 10 5
T cells in a well of the 96-well tissue culture plates . The
amount of a mAb in each antibody preparation was stan-
dardized so that thesame dilution ofthe ascites fluids con-
tained thesame cytotoxic titerand the same dilution ofthe
purified antibodies contained the same concentration ofthe
protein . Note lack ofthe inhibition with the anti-I-Ak mAb,
and the intermediate inhibitory effect ofthe anti-I-E k mAb
in B (arrows) . Symbols : O, anti-I-Ab (25-9-17S); A, anti-
I-Ab (28-16-8S) ; " , anti-I-Ak (10-3.6); A, anti-I-Ek
(14-4-45) ; 0, anti-Kb (28-13-3S) ; /, anti-Kk (11-4.1).MIYAZAWA ET AL.
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sponse under the stimulation of H-211 PECs with the anti-I-A' mAb was not be-
cause we used an antibody of inappropriate specificity or inadequate affinity. Fig.
6, C-E show the results of control experiments in which the inhibition of TNP-
KLH-specific Tcell proliferative response was analyzed. As shown in Fig. 6, C-E,
the anti-I-A and anti-I-E mAbs used in these experiments had appropriate haplo-
type specificityandadequate affinity to inhibitT cell proliferativeresponses. Moreover,
all the anti-I-A and anti-I-E mAbs used inhibited the T cell proliferative response
through their binding to APC, but not by the binding to T cells, because only the
mAbs directed to MHC antigens expressed on PEG, but not the mAbs directed to
the MHC molecules that are expressed on T cells but absent on PEG, inhibited
the proliferation (Fig. 6, compare C and E). Thus, these results directly indicate
that FMuLV envelope-specific T cells from H-2" mice recognize the envelope pro-
tein in association with I-Ab, hybrid I-A, and/or hybrid I-E" class II MHC mol-
ecules expressed on APC.
bm12 Mutation Abolished T Cell Responsiveness to F-MuLVEnvelope Protein.
￿
Both of
the anti-I-Ab mAbs that inhibited the FMuLV envelope-specific T cell prolifera-
tive responses under the stimulation ofH-2db PEG in previous section do not react
with the mutant I-A molecule ofB6.C-H-2''"12 (bm12) mice (44). This mutation oc-
curred in the 01 exon ofthe Apb gene (45, 46). Therefore, it was ofinterest to test
whether the presence of wild-type Apb chain was essential for the recognition of
FMuLV envelope glycoprotein by T cells. We hence immunized both (B10.A x
A.BY)Fi (H-2) and (bm12 x A/WySn)Fi (H-2'"'12'mice with the vaccinia-FMuLV
envvaccine, and tested the envelope-specific T cell proliferative responses under the
stimulation ofPECs elicited from thesetwo strains ofmice. T cells from immunized
(B10.A x A.BY)Fj mice, again, proliferated strongly under the stimulation of syn-
geneic PEG pulsed with FMuLV(Fig. 7). However, T cells from immunized (bm12
x A/WySn)Fi mice did not show any significant envelope-specific proliferative re-
sponses both under the stimulation of syngeneic PEG and under the stimulation
of H-2al' PEG (Fig. 7, squares). Therefore, T cells were not primed with FMuLV
envelope protein in H-2'm" mice.
The envelope-specific proliferative responses ofH-gal' T cells underthe stimula-
tion of H-2'-" PEG were significantly lower than those under the stimulation of
syngeneic PEG (Fig. 7 and Table IV). In three of the five repeated experiments,
the Acpm values obtained under the stimulation of H-2b-11 PEG were marginal.
However, relatively high level ofenvelope-specific proliferative responses were ob-
served in two other experiments (Table IV). Thus, the expression of wild-type ADb
chainwasdefinitely required to prime Tcells with FMuLV envelopeprotein invivo,
and antigen-presenting activity of H-2b-11 PECs to the envelope-specific T cells
was, at least, lower than that of H-2alb PEG, but we could not distinguish whether
the lack ofT cell priming with FMuLV envelope protein in H-2b"21" mice was due
to a restricted T cell repertoire or reduced antigen-presenting activity to enve-
lope-specific T cells, or both.
Discussion
In this report wehave clearly demonstrated an influence ofthe H-2 on presenta-
tion of FMuLV envelope protein to specifically primed proliferative T cells. APC
having the dominant H-2' haplotype can present the envelope protein to immune
T cells and can induce a Tcell proliferative response, while APC having only the1598
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FIGURE 7 .
￿
Proliferative responses ofFMuLV envelope-
specific T cells from (B10.A x A.BY)F, and (bm12 x
A/WySn)Fl mice under the stimulation of syngeneic and
coisogenic PEC. Mice were immunizedwith the vaccinia-
FMuLVenvrecombinant vaccine as described andimmune
T cellswere prepared from 16 to 20 d after theimmuniza-
tion . PEC were pulsed with UVirradiated F-MuLV (FB-
29), and indicated numbers ofPEC were cultured with 5
x 10 5T cells per well . The results of three repeated ex-
periments were completely consistent with this representa-
tive figure . Each Acpm value shows mean t SD.
H-2° haplotype cannot (Fig . 3) . This phenomenon is not caused by general func-
tional impairment of APC having the H-2° genotype because in the control ex-
periments H-Z" APC presented the antigen to TNP-KLH-primed T cells as effec-
tively as H-2' APC did (Fig . 2) . Genetic mapping experiments show that the
gene(s) controlling the antigen-presenting activity to FMuLV envelope-specific T
cells is located in K- or I-region loci of the H-2 (Fig . 4) . Moreover,Tcells in (B10.MBR
x A/WySn)F1 mice that have the Kbik, I-A' genotype cannot be primed with the
envelope antigen (Fig . 5) . The most likely explanation for this influence of the H-2
on antigen-presenting activity is that FMuLV envelope-specific T cells in H-2alb
TABLE IV
Proliferative Responses ofF-MuLV Envelope-speck H-2db T Cells under the Stimulation of
Syngeneic I-A,lb or Coisogenic I-Abml2/k pEC Pulsed with UV-irradiated F-MuLV (FB-29)
` The schedule of immunization was the same as that described in Table III .
t Stimulator cell dose-response curves were analyzed in each of these experiments and the results are repre-
sented here by peak Acpm values .
5 These Acpm values are significantly higher than the other value ofthe same experiment (p< 0.05 by Stu-
dent's t test) .
lays after [3H]Thymidine incorporation by
Immunization of final No . ofPEC 5 x 105 T cells (Acpm value) under
(B10A x A.BY)Fj
mice in vivo *
immuni-
zation
added per
wellt (BIO.A
the stimulation
x A.BY)Fj
ofPEC from
(bml2 x A/WySn)Fl
Once 16 10 5 14,305 t 1,400§ 1,890 t 2,563
Once 17 3 x 10 4 14,590 t 821S 7,722 t 1,536
Once 19 105 4,666 t 1,0225 1,297 t 1,119
Twice 10 3 x 10 4 12,133 t 1,8935 3,154 t 616
Twice 13 3 x 10 4 13,007 t 2,306 8,179 t 2,235MIYAZAWA ET AL .
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mice recognize the envelope protein only in association with I-A', hybrid I-A",
and/or hybrid I-E' molecules .
To demonstrate directly that these class II MHC molecules were actually func-
tioning as restriction elements in the recognition ofFMuLV envelope antigen by
T cells, we did blocking experiments with anti-H-2 mAbs (Fig . 6) . Both of the two
anti-I-Ab mAbs used strongly inhibited the FMuLV envelope-specific T cell
proliferative response under the stimulation ofH-2' or H-26ib PEC, while the anti-
Kb, anti-Kk , and, more importantly, anti-I-Ak mAbs did not block even when the
T cells were stimulated with heterozygous H-2" PEC. Since both of the anti-I-Ab
mAbs used in this study do not react with the mutant I-A molecule of bm12 mice
(44), the presence of wild-type Apb chain seems to be essential for the formation
of the antigenic determinants recognized with these mAbs . In addition, the anti-
genic determinant recognized with anti-I-Ak mAb 10-3 .6 is located on AOk chain
(47) . Therefore, within the limitation ofmAbs used, the results of our blocking ex-
periments, alongwith the results obtained with the H-2 recombinant mice, indicate
thatAabApb and possibly A,'Apb class II molecules are the restriction elements for
FMuLV envelope-specific T cells, while AakApk and AabApk molecules are not.
Importance ofApb chain inT cell recognition of FMuLV envelope protein is fur-
ther substantiated by the experiments usingthe mutant bm12 mice. T cells are not
primed with the envelope antigen in (bm12 x A/WySn)Fi mice (Fig. 7), andFMuLV
envelope-specificT cells from H-Z" mice are more efficiently stimulated with syn-
geneic PEC than with IA'-" PEC (Fig . 7 and Table IV). Therefore, Apb chain
seems to play a critical role in stimulationofFMuLVenvelope-specific proliferative
T cells . In addition, although (bm12 x A/WySn)Fl PEC are thought to express
AabApk hybrid class II molecules alongwith AabApbml2, AakApbmt2, andAakApk mol-
ecules, there is no complementation effect by this hybrid I-Amolecule to stimulate the
envelope-specific T cells. This result further supports the conclusion that AabApk
molecule is not involved in T cell recognition of F-MuLV envelope antigen .
Since H-gala APC that express I-Ek as well as I-Ak molecules cannot present the
envelope glycoprotein to specifically primed T cells, it is a somewhat unexpected
finding that anti-I-Ek mAb 14-4-4S induced intermediate, but statistically
significant, inhibition of the envelope-specific T cell proliferative response under
the stimulation of H-2alb PEC (Fig . 6 B) . However, since this mAb has specificity
of Ia.7 (43) and the antigenic determinant for this specificity is expressed on the
Eak subunit (8), this inhibitory effect is probably mediated by a steric effect caused
by binding of the mAb to Eak chain of the EakEpb complex. Thus, it is likely that,
in addition to I-Ab- and hybrid I-Alb-restricted T cells, some (small) population
ofFMuLV envelope-specificT cells in H-2' mice do recognize the antigen in the
context ofEakEpb . Marginal proliferative responses ofH-2" T cells under the stim-
ulation of H-2b,r21a PEC might also be mediated by this hybrid I-E molecule .
The envelope protein ofFMuLV is a large, complex molecule that is composed
of675 amino acids and several carbohydrate chains (48), and it has at least several
different antigenic determinants distinguishable with mAbs (31, 32, 49, 50) . It is,
therefore, quite surprising that the same molecule does not have anyT cell deter-
minants that can be recognized in association with H-2aMHC products . From the
results of their extensive analyses on the interaction between protein-derived im-
munogenic peptides and class IIMHC molecules, Buus et al . (51) have calculated1600
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that each class II molecule can bind >50% ofimmunogenic peptides of 10-17 amino
acids and even 10-20% of unbiased (not only immunogenic) small peptides . In this
regard, it would be difficult to imagine that none of the peptides derived from such
a big molecule as FMuLV envelope glycoprotein can be bound by I-Ak or I-Ek mol-
ecule . On the otherhand, since envelope glycoprotein ofendogenous murine leukemia
viruses is expressed as a differentiation antigen during the normal development of
hematopoietic precursor cells and reproductive systems (52, 53), it is possible that
T cell repertoire for recognition of the FMuLV envelope protein is somewhat re-
stricted by self-tolerance to endogenous retroviral antigens . In fact, lack of T cell
responsiveness to FMuLV envelope protein in (bm12 x A/WySn)Fl mice strongly
suggests that T cells recognize a very limited number of epitopes on the envelope
antigen . For most of the variety of antigens tested, the immune responsiveness of
coisogenic C57BL/6 (B6) and bm12 mice were found to be indistinguishable (sum-
marized in reference 54) . H-Y antigen and beef insulin are the only two exceptions
wherebm12 mice arenonresponders andB6 areresponders (54) . Interestingly, analyses
using heterologous insulins (54, 55) have demonstrated that only one amino acid
change between beefand sheep insulins is responsible for the different immune re-
sponsiveness between bm12 and B6 mice . Therefore, it is possible that T cell reper-
toire for recognition of FMuLV envelope protein is restricted to only one epitope
defined by a few amino acid(s) . Comparison ofT cell responsiveness to endogenous
versus exogenous retroviral envelope proteins in H-26 and H-2`12 mice might pro-
vide further evidence to evaluate this hypothesis .
The Ir gene control ofTcell responsiveness toFMuLVenvelope protein described
here is completely consistent with our previous results of in vivo immune protection
experiments (25, 26) . In fact, the mice having the responder b allele at I region loci
of the H-2 are protectively immunized against FV with the vaccinia-FMuLV env
recombinant vaccine, while the mice having only the nonresponder k allele in these
loci are not protected (26) . Since it has previously been shown that the protective
immunity against FV is functionally associated with priming of helperT cells with
FMuLV envelope (25, 26), it is now quite appropriate to conclude that the Ir genes
forFMuLVenvelope proteindo control theinduction ofhelperTcells in vivo. How-
ever, the role of thesame Ir genes in spontaneous recovery from FVinduced leukemia
is still unclear. Ourprevious studies (17, 19) have demonstrated that the H-2D locus
strongly influences spontaneous recovery from FVinduced splenomegaly. This
influence appears to act by controlling thetime course of the development of Friend
leukemia cell-specific T cell proliferative response in FVinfected mice (24) . The
mechanism by which the H-2D locus influences the dynamics ofT cell response
is unknown. However, the mice having the d/b or d/d allele at the D locus do not
recoverfrom high-dose inoculation ofFV evenwhen they have the responder b allele
at theH-2I region (Table I) . Therefore, the effect ofH-2D locus is apparently stronger
than that of the Ir genes to FMuLV envelope. Interestingly, when inoculated with
a low dose of FV, H-2alb as well as H-2' mice recover spontaneously from spleno-
megaly, while H-2°l° mice do not (Table I) . We are currently examining whether
there is a possible requirement for the responder b allele at H-2I for spontaneous
recovery of H-2D Ib mice from low-dose inoculation of FV.
Finally, one recent study (56) suggested that similar Ir gene phenomenon mightMIYAZAWA ET AL .
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control the T cell responsiveness in humans againsthumanTlymphotropic virus
type-I (HTLVI) . Low responsiveness ofT cells against the human retrovirus was
associated with the development of leukemia (56) . Based on our present results, low
responsiveness ofT cells to retroviral antigens may also cause lack of or insufficient
protective immunity after immunization . Therefore, it will probably be necessary
to overcome genetic restrictions of the antiretrovirus immune response when at-
tempting to induce protective immunity against human retrovirus infection. In this
regard, our previous study (26) demonstrated that nonresponders toFMuLV enve-
lope protein could be protected against FV when they were immunized with fixed
FMuLV particles in CFA. Furthermore, alow, butsignificant, level ofTcell prolifer-
ative response under the stimulation ofH-2"° PEC was observed when the H-2°~b
mice were immunized with purifiedRMuLV virions in CFA (Fig . 1 and Table II) .
This apparent bypassing oftheIr gene phenomenon mightbe due to immunization
ofmice with larger amounts ofantigen, useof highly immunostimulatory adjuvant,
or simply due to the priming ofT cells with the gag and/or polgene products . This
latter possibility is currentlybeingtestedby using recombinantvaccinia viruses that
express the FMuLV gag gene .
Summary
T cells primed specifically for theenvelope glycoprotein ofFriend murine leukemia
helper virus(FMuLV)were prepared byimmunizing mice with arecombinant vac-
cinia virus that expressed the entire env gene ofFMuLV Significant proliferative
responses ofFMuLV envelope-specific, H-2" T cells were observed when theT
cellswere stimulated with antigen-pulsed peritoneal exudate cells(PEC) having the
b allele at the K, As, Ac, and ED loci of the H-2 . On the other hand, PEC having
only thekallele at these loci did notinduce theenvelope-specificT cell proliferation,
even when the PEC had the b allele at the Ea , S, or D loci . FMuLV enve-
lope-specific proliferation of H-2a'T cells under the stimulation of antigen-pulsed,
H-2db PEC was specifically blocked with anti-I-A' and anti-I-E' mAbs but not with
anti-Kb, anti-Kk, or anti-I-Al mAbs . Moreover, (B10.MBR x A/WySn)Fi mice that
have the b allele only at the K locus but not in I-A subregion were nonresponders
to the envelope glycoprotein, and the bm12 mutation at the AD locus completely
abolished the T cell responsiveness to this antigen.
These results indicate that proliferativeT cellsrecognizealimitednumber of epi-
topes onFMuLV envelope protein in the context of I-Ab , hybrid I-Alb, and/or hy-
brid I-Ewb class IIMHC molecules but fail to recognize the same envelope protein
in the context of I-Ak or I-Ek molecules . This influence of the H-2I region on T
cell recognition of the envelope glycoprotein appeared to control in vivo induction
of protective immunity against Friend virus complex after immunization with the
vaccinia-FMuLV env vaccine . Thus, these results provide, for the first time, direct
evidence forIr gene-controlledresponder/nonresponder phenotypes influencingthe
immune response to a pathogenic virus of mice .
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